Health risk and biological effects of cardiac ionising imaging: from epidemiology to genes
- PMID: 19578466
- PMCID: PMC2705223
- DOI: 10.3390/ijerph6061882
Health risk and biological effects of cardiac ionising imaging: from epidemiology to genes
Abstract
Cardiac diagnostic or therapeutic testing is an essential tool for diagnosis and treatment of cardiovascular disease, but it also involves considerable exposure to ionizing radiation. Every exposure produces a corresponding increase in cancer risk, and risks are highest for radiation exposure during infancy and adolescence. Recent studies on chromosomal biomarkers corroborate the current radioprotection assumption showing that even modest radiation load due to cardiac catheter-based fluoroscopic procedures can damage the DNA of the cell. In this article, we review the biological and clinical risks of cardiac imaging employing ionizing radiation. We also discuss the perspectives offered by the use of molecular biomarkers in order to better assess the long-term development of health effects.
Keywords: DNA damage; biomarkers; cancer risk; genetic polymorphisms; ionizing radiation.
Figures





References
-
- Mettler FA, Thomadsen BR, Bhargavan M, Gilley DB, Gray JE, Lipoti JA, McCrohan J, Yoshizumi TT, Mahesh M. Medical radiation exposure in the U.S. in 2006: preliminary results. Health Phys. 2008;95:502–507. - PubMed
-
- Amis ES, Butler PF, Applegate KE, Birnbaum SB, Brateman LF, Hevezi JM, Mettler FA, Morin RL, Pentecost MJ, Smith GG, Strauss KJ, Zeman RK. American College of Radiology white paper on radiation dose in medicine. J. Am. Coll. Radiol. 2007;4:272–284. - PubMed
-
- Karatzis EN, Danias PG. Exposure to ionizing radiation from cardiovascular imaging and therapeutic procedures may be a considerable unrecognized risk for subsequent cancer. J. Am. Coll. Radiol. 2008;5:694–695. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources